These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 28591114)
1. First deuterated drug approved. Schmidt C Nat Biotechnol; 2017 Jun; 35(6):493-494. PubMed ID: 28591114 [No Abstract] [Full Text] [Related]
2. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Russak EM; Bednarczyk EM Ann Pharmacother; 2019 Feb; 53(2):211-216. PubMed ID: 30136594 [TBL] [Abstract][Full Text] [Related]
3. Deuterated Drug Molecules: Focus on FDA-Approved Deutetrabenazine DeWitt SH; Maryanoff BE Biochemistry; 2018 Feb; 57(5):472-473. PubMed ID: 29160059 [No Abstract] [Full Text] [Related]
5. Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome. Paton DM Drugs Today (Barc); 2017 Feb; 53(2):89-102. PubMed ID: 28387387 [TBL] [Abstract][Full Text] [Related]
6. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease. Dean M; Sung VW Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277 [TBL] [Abstract][Full Text] [Related]
7. Deutetrabenazine-Not a Revolution but Welcome Evolution for Treating Chorea in Huntington Disease. Reilmann R JAMA Neurol; 2016 Dec; 73(12):1404-1406. PubMed ID: 27749952 [No Abstract] [Full Text] [Related]
8. Two New Drugs for Tardive Dyskinesia Hit the Market. Morrow T Manag Care; 2018 Jan; 27(1):35-36. PubMed ID: 29369770 [TBL] [Abstract][Full Text] [Related]
9. Valbenazine: First Global Approval. Kim ES Drugs; 2017 Jul; 77(10):1123-1129. PubMed ID: 28578484 [TBL] [Abstract][Full Text] [Related]
10. Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia. Davis MC; Miller BJ; Kalsi JK; Birkner T; Mathis MV N Engl J Med; 2017 Jun; 376(26):2503-2506. PubMed ID: 28489481 [No Abstract] [Full Text] [Related]
14. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease. Heo YA; Scott LJ Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203 [TBL] [Abstract][Full Text] [Related]
15. Recent Updates on the Development of Deuterium-Containing Drugs for the Treatment of Cancer. Belete TM Drug Des Devel Ther; 2022; 16():3465-3472. PubMed ID: 36217450 [TBL] [Abstract][Full Text] [Related]